Aurobindo Pharma today said that different funds belonging to HDFC Trustee Company had purchased 5.01% stake in the firm.
Different funds of HDFC Trustee Company have purchased 145,93,640 equity shares amounting to 5.01% of the paid up equity share capital, Aurobindo Pharma said in a filing to the Bombay Stock Exchange (BSE).
The purchase was carried out in open market on and the company did not provide the value of the acquisition. However, based on closing price of Aurobindo Pharma's scrips of Rs 143.70 per share on August 18 on the BSE, the stake would be worth nearly Rs 210 crore.
The different funds of HDFC Trustee Company which bought stake in Aurobindo Pharma include, HDFC arbitrage fund, HDFC balanced fund, HDFC equity fund, HDFC prudence fund, HDFC top 200 fund and HDFC mid cap opportunities.
Shares of Aurobindo Pharma today closed at Rs 137.10 on the BSE, down 4.59% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
